Valuation: Fusen Pharmaceutical Company Limited

Market Cap 53Cr 62Cr 7.91Cr 7.04Cr 6.53Cr 5.91Cr 11Cr 749.58Cr 11Cr 78Cr 31Cr 392.26Cr 30Cr 29Cr 1.25TCr P/E 2024
-2.95x
P/E 2025 -45.1x
Enterprise Value 75Cr 88Cr 11Cr 10Cr 9.27Cr 8.4Cr 16Cr 1.06TCr 16Cr 111.22Cr 44Cr 557.02Cr 42Cr 41Cr 1.78TCr EV / Sales 2024
2.83x
EV / Sales 2025 2.76x
Free-Float
26.11%
Yield 2024 *
-
Yield 2025 -
1 day-4.76%
1 week-13.98%
Current month-11.11%
1 month-2.44%
3 months-23.08%
6 months-32.20%
1 week 0.76
Extreme 0.765
0.9
1 month 0.72
Extreme 0.72
1.05
Current year 0.67
Extreme 0.67
1.44
1 year 0.64
Extreme 0.64
1.44
3 years 0.24
Extreme 0.235
1.75
5 years 0.24
Extreme 0.235
2.74
10 years 0.24
Extreme 0.235
20
Manager TitleAgeSince
Director of Finance/CFO 48 18/04/2019
Investor Relations Contact 40 18/01/2013
Corporate Secretary 36 30/09/2024
Director TitleAgeSince
Director/Board Member 63 07/04/2017
Director/Board Member 64 07/04/2017
Director/Board Member 61 07/04/2017
Date Insider Type Main position Quantity % Market Cap. Importance
19/04/24 Other

Chairman

6,50,000 0.0867%
18/04/24 Other

Chairman

2,40,000 0.0320%
18/04/24 Other

Chairman

2,40,000 0.0320%
Change 5-day change 1-year change 3-year change Capi.($)
-4.76%-13.98%+9.59%-46.67% 8.15Cr
+3.49%+10.04%+58.68%+119.56% 1,10600Cr
+2.19%+4.32%+33.88%+69.52% 61TCr
+2.26%+5.37%+24.57%+97.69% 50TCr
+2.58%+8.37%+38.71%+63.14% 37TCr
+3.25%+4.45%+71.80%+44.44% 35TCr
+1.85%+6.04%+21.47%+49.17% 29TCr
+1.76%+6.07%+0.43%+20.98% 26TCr
+3.29%+6.32%+44.71%+57.43% 23TCr
+2.25%+5.81%+27.13%+101.17% 19TCr
Average +1.36%+2.29%+33.10%+57.64% 39TCr
Weighted average by Cap. +1.43%+4.67%+40.82%+80.58%

Financials

2024 2025
Net sales 33Cr 38Cr 4.88Cr 4.34Cr 4.03Cr 3.65Cr 6.86Cr 462.37Cr 6.97Cr 48Cr 19Cr 241.97Cr 18Cr 18Cr 771.91Cr 27Cr 32Cr 4.09Cr 3.64Cr 3.38Cr 3.06Cr 5.75Cr 387.69Cr 5.85Cr 41Cr 16Cr 202.88Cr 15Cr 15Cr 647.22Cr
Net income -19Cr -22Cr -2.83Cr -2.52Cr -2.33Cr -2.11Cr -3.97Cr -267.73Cr -4.04Cr -28Cr -11Cr -140.11Cr -11Cr -10Cr -446.97Cr -1.18Cr -1.38Cr -17.64L -15.7L -14.55L -13.19L -24.78L -17Cr -25.2L -1.75Cr -68.6L -8.75Cr -66.17L -64.8L -28Cr
Net Debt 37Cr 43Cr 5.5Cr 4.89Cr 4.54Cr 4.11Cr 7.72Cr 520.83Cr 7.85Cr 54Cr 21Cr 272.56Cr 21Cr 20Cr 869.49Cr 22Cr 26Cr 3.32Cr 2.96Cr 2.74Cr 2.48Cr 4.67Cr 314.83Cr 4.75Cr 33Cr 13Cr 164.75Cr 12Cr 12Cr 525.59Cr
Projected Income Statement - Annual - Fusen Pharmaceutical Company Limited
Logo Fusen Pharmaceutical Company Limited
Fusen Pharmaceutical Co Ltd is a company mainly engaged in the cultivation of Chinese herbal medicine, pharmaceutical research and development, and sales. The Company's main business is the sales of Shuanghuanglian Oral Solutions, Shuanghuanglian Injections and other pharmaceutical products. The Company is also engaged in the research, production, and sales of various proprietary Chinese medicine and western medicine products for treating cold, fever, cardiovascular diseases and anemia. The Company mainly conducts business in the domestic market.
Employees
817
Date Price Change Volume
21/26/21 HK$0.8000 -4.76% 20,000
20/26/20 HK$0.8400 -2.89% 49,000
16/26/16 HK$0.8650 0.00% 0
15/26/15 HK$0.8650 -6.99% 23,000
14/26/14 HK$0.9300 0.00% 1,000
  1. Stock Market
  2. Stocks
  3. 1652 Stock